Vaccine Exec Named SBRI Chair

10/1/09Follow @xconomy

Todd Patrick, a longtime vaccine company executive, has been named the chairman of the board of trustees at Seattle Biomedical Research Institute. Patrick is the former president of ID Biomedical, the Vancouver, BC and Bothell, WA-based vaccine developer that was acquired by GlaxoSmithKline for $1.5 billion in 2005. Patrick has served on the SBRI board for two years, and takes the chairmanship as the nonprofit research institute prepares to advance a novel malaria vaccine candidate from the lab to its first clinical trial in early 2010.

By posting a comment, you agree to our terms and conditions.